WallStSmart

Sandisk Corp (SNDK)vsThermo Fisher Scientific Inc (TMO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Thermo Fisher Scientific Inc generates 243% more annual revenue ($45.20B vs $13.18B). SNDK leads profitability with a 34.2% profit margin vs 15.1%. TMO trades at a lower P/E of 25.8x. SNDK earns a higher WallStSmart Score of 69/100 (B-).

SNDK

Strong Buy

69

out of 100

Grade: B-

Growth: 7.3Profit: 10.0Value: 3.7Quality: 8.0
Piotroski: 4/9Altman Z: 1.82

TMO

Buy

62

out of 100

Grade: C+

Growth: 4.7Profit: 7.0Value: 4.7Quality: 5.3
Piotroski: 3/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

SNDKSignificantly Overvalued (-52.4%)

Margin of Safety

-52.4%

Fair Value

$413.56

Current Price

$1096.51

$682.95 premium

UndervaluedFair: $413.56Overvalued
TMOOvervalued (-14.2%)

Margin of Safety

-14.2%

Fair Value

$408.60

Current Price

$462.60

$54.00 premium

UndervaluedFair: $408.60Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SNDK6 strengths · Avg: 10.0/10
Return on EquityProfitability
39.3%10/10

Every $100 of equity generates 39 in profit

Profit MarginProfitability
34.2%10/10

Keeps 34 of every $100 in revenue as profit

Operating MarginProfitability
70.0%10/10

Strong operational efficiency at 70.0%

Revenue GrowthGrowth
251.0%10/10

Revenue surging 251.0% year-over-year

EPS GrowthGrowth
618.0%10/10

Earnings expanding 618.0% YoY

Debt/EquityHealth
0.0810/10

Conservative balance sheet, low leverage

TMO1 strengths · Avg: 9.0/10
Market CapQuality
$174.37B9/10

Large-cap with strong market position

Areas to Watch

SNDK3 concerns · Avg: 4.0/10
P/E RatioValuation
37.5x4/10

Premium valuation, high expectations priced in

Price/BookValuation
15.9x4/10

Trading at 15.9x book value

Altman Z-ScoreHealth
1.824/10

Grey zone — moderate risk

TMO3 concerns · Avg: 3.7/10
PEG RatioValuation
1.544/10

Expensive relative to growth rate

P/E RatioValuation
25.8x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : SNDK

The strongest argument for SNDK centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 34.2% and operating margin at 70.0%. Revenue growth of 251.0% demonstrates continued momentum.

Bull Case : TMO

The strongest argument for TMO centers on Market Cap. Profitability is solid with margins at 15.1% and operating margin at 17.9%.

Bear Case : SNDK

The primary concerns for SNDK are P/E Ratio, Price/Book, Altman Z-Score.

Bear Case : TMO

The primary concerns for TMO are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

SNDK profiles as a growth stock while TMO is a mature play — different risk/reward profiles.

SNDK is growing revenue faster at 251.0% — sustainability is the question.

SNDK generates stronger free cash flow (980M), providing more financial flexibility.

Monitor COMPUTER HARDWARE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SNDK scores higher overall (69/100 vs 62/100), backed by strong 34.2% margins and 251.0% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Sandisk Corp

TECHNOLOGY · COMPUTER HARDWARE · USA

Sandisk Corporation (Ticker: SNDK) is a U.S.-based technology company that develops, manufactures, and sells data storage products and solutions built on NAND flash memory technology, including solid-state drives (SSDs), embedded storage, memory cards, and USB flash drives for consumer, enterprise, and cloud computing markets.

Visit Website →

Thermo Fisher Scientific Inc

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues.

Visit Website →

Want to dig deeper into these stocks?